Trump nominated White House domestic policy aide Dr. Heidi Overton on August 18-19, 2026, to serve as FDA Commissioner following the May resignation of Dr. Marty Makary. Overton, a physician and deputy director of the Domestic Policy Council with prior ties to the America First Policy Institute, must secure Senate confirmation through the narrowly Republican-controlled HELP Committee chaired by Sen. Bill Cassidy. Cassidy has voiced strong reservations over her limited managerial experience and role in recent vaccine-related executive actions. The agency continues operating under Acting Commissioner Kyle Diamantas amid ongoing staff turnover and leadership stabilization moves announced in early September. Confirmation timing and outcome hinge on committee hearings, potential holds, and floor vote dynamics in a divided Senate.
Polymarketデータを参照したAI生成の実験的な要約。これは取引アドバイスではなく、このマーケットの解決方法には一切関係ありません。 · 更新日$19,662 Vol.
2026/09/30
9月30日
9%
10月31日
36%
11月30日
30%
12月31日
55%
$19,662 Vol.
9月30日
$11,104 Vol.
9%
10月31日
$4,762 Vol.
36%
11月30日
$1,097 Vol.
30%
12月31日
$2,700 Vol.
55%
This market will resolve to “Yes” if Heidi Overton is confirmed as Commissioner of the U.S. Food and Drug Administration by September 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to “No”.
If Heidi Overton's nomination is formally withdrawn, or if the Senate rejects the nomination, this market will immediately resolve to “No”.
The Senate must confirm this nominee as Commissioner of the U.S. Food and Drug Administration for this market to resolve to "Yes". Recess appointments without Senate confirmation will not count toward a "Yes" resolution.
The primary resolution source for this market is official information from the U.S. Senate; however, a consensus of credible reporting may also be used.This market will resolve to “Yes” if Heidi Overton is confirmed as Commissioner of the U.S. Food and Drug Administration by October 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to “No”.
If Heidi Overton's nomination is formally withdrawn, or if the Senate rejects the nomination, this market will immediately resolve to “No”.
The Senate must confirm this nominee as Commissioner of the U.S. Food and Drug Administration for this market to resolve to "Yes". Recess appointments without Senate confirmation will not count toward a "Yes" resolution.
The primary resolution source for this market is official information from the U.S. Senate; however, a consensus of credible reporting may also be used.This market will resolve to “Yes” if Heidi Overton is confirmed as Commissioner of the U.S. Food and Drug Administration by November 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to “No”.
If Heidi Overton's nomination is formally withdrawn, or if the Senate rejects the nomination, this market will immediately resolve to “No”.
The Senate must confirm this nominee as Commissioner of the U.S. Food and Drug Administration for this market to resolve to "Yes". Recess appointments without Senate confirmation will not count toward a "Yes" resolution.
The primary resolution source for this market is official information from the U.S. Senate; however, a consensus of credible reporting may also be used.This market will resolve to “Yes” if Heidi Overton is confirmed as Commissioner of the U.S. Food and Drug Administration by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to “No”.
If Heidi Overton's nomination is formally withdrawn, or if the Senate rejects the nomination, this market will immediately resolve to “No”.
The Senate must confirm this nominee as Commissioner of the U.S. Food and Drug Administration for this market to resolve to "Yes". Recess appointments without Senate confirmation will not count toward a "Yes" resolution.
The primary resolution source for this market is official information from the U.S. Senate; however, a consensus of credible reporting may also be used.Trump nominated White House domestic policy aide Dr. Heidi Overton on August 18-19, 2026, to serve as FDA Commissioner following the May resignation of Dr. Marty Makary. Overton, a physician and deputy director of the Domestic Policy Council with prior ties to the America First Policy Institute, must secure Senate confirmation through the narrowly Republican-controlled HELP Committee chaired by Sen. Bill Cassidy. Cassidy has voiced strong reservations over her limited managerial experience and role in recent vaccine-related executive actions. The agency continues operating under Acting Commissioner Kyle Diamantas amid ongoing staff turnover and leadership stabilization moves announced in early September. Confirmation timing and outcome hinge on committee hearings, potential holds, and floor vote dynamics in a divided Senate.
This market will resolve to “Yes” if Heidi Overton is confirmed as Commissioner of the U.S. Food and Drug Administration by September 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to “No”.
If Heidi Overton's nomination is formally withdrawn, or if the Senate rejects the nomination, this market will immediately resolve to “No”.
The Senate must confirm this nominee as Commissioner of the U.S. Food and Drug Administration for this market to resolve to "Yes". Recess appointments without Senate confirmation will not count toward a "Yes" resolution.
The primary resolution source for this market is official information from the U.S. Senate; however, a consensus of credible reporting may also be used.
If Heidi Overton's nomination is formally withdrawn, or if the Senate rejects the nomination, this market will immediately resolve to “No”.
The Senate must confirm this nominee as Commissioner of the U.S. Food and Drug Administration for this market to resolve to "Yes". Recess appointments without Senate confirmation will not count toward a "Yes" resolution.
The primary resolution source for this market is official information from the U.S. Senate; however, a consensus of credible reporting may also be used.
マーケット開始日： Aug 20, 2026, 5:43 PM ET
音量
$19,662終了日
2027/01/01マーケット開始日
Aug 20, 2026, 5:43 PM ETリゾルバー
0x65070BE91...This market will resolve to “Yes” if Heidi Overton is confirmed as Commissioner of the U.S. Food and Drug Administration by September 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to “No”.
If Heidi Overton's nomination is formally withdrawn, or if the Senate rejects the nomination, this market will immediately resolve to “No”.
The Senate must confirm this nominee as Commissioner of the U.S. Food and Drug Administration for this market to resolve to "Yes". Recess appointments without Senate confirmation will not count toward a "Yes" resolution.
The primary resolution source for this market is official information from the U.S. Senate; however, a consensus of credible reporting may also be used.This market will resolve to “Yes” if Heidi Overton is confirmed as Commissioner of the U.S. Food and Drug Administration by October 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to “No”.
If Heidi Overton's nomination is formally withdrawn, or if the Senate rejects the nomination, this market will immediately resolve to “No”.
The Senate must confirm this nominee as Commissioner of the U.S. Food and Drug Administration for this market to resolve to "Yes". Recess appointments without Senate confirmation will not count toward a "Yes" resolution.
The primary resolution source for this market is official information from the U.S. Senate; however, a consensus of credible reporting may also be used.This market will resolve to “Yes” if Heidi Overton is confirmed as Commissioner of the U.S. Food and Drug Administration by November 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to “No”.
If Heidi Overton's nomination is formally withdrawn, or if the Senate rejects the nomination, this market will immediately resolve to “No”.
The Senate must confirm this nominee as Commissioner of the U.S. Food and Drug Administration for this market to resolve to "Yes". Recess appointments without Senate confirmation will not count toward a "Yes" resolution.
The primary resolution source for this market is official information from the U.S. Senate; however, a consensus of credible reporting may also be used.This market will resolve to “Yes” if Heidi Overton is confirmed as Commissioner of the U.S. Food and Drug Administration by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to “No”.
If Heidi Overton's nomination is formally withdrawn, or if the Senate rejects the nomination, this market will immediately resolve to “No”.
The Senate must confirm this nominee as Commissioner of the U.S. Food and Drug Administration for this market to resolve to "Yes". Recess appointments without Senate confirmation will not count toward a "Yes" resolution.
The primary resolution source for this market is official information from the U.S. Senate; however, a consensus of credible reporting may also be used.Trump nominated White House domestic policy aide Dr. Heidi Overton on August 18-19, 2026, to serve as FDA Commissioner following the May resignation of Dr. Marty Makary. Overton, a physician and deputy director of the Domestic Policy Council with prior ties to the America First Policy Institute, must secure Senate confirmation through the narrowly Republican-controlled HELP Committee chaired by Sen. Bill Cassidy. Cassidy has voiced strong reservations over her limited managerial experience and role in recent vaccine-related executive actions. The agency continues operating under Acting Commissioner Kyle Diamantas amid ongoing staff turnover and leadership stabilization moves announced in early September. Confirmation timing and outcome hinge on committee hearings, potential holds, and floor vote dynamics in a divided Senate.
This market will resolve to “Yes” if Heidi Overton is confirmed as Commissioner of the U.S. Food and Drug Administration by September 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to “No”.
If Heidi Overton's nomination is formally withdrawn, or if the Senate rejects the nomination, this market will immediately resolve to “No”.
The Senate must confirm this nominee as Commissioner of the U.S. Food and Drug Administration for this market to resolve to "Yes". Recess appointments without Senate confirmation will not count toward a "Yes" resolution.
The primary resolution source for this market is official information from the U.S. Senate; however, a consensus of credible reporting may also be used.
If Heidi Overton's nomination is formally withdrawn, or if the Senate rejects the nomination, this market will immediately resolve to “No”.
The Senate must confirm this nominee as Commissioner of the U.S. Food and Drug Administration for this market to resolve to "Yes". Recess appointments without Senate confirmation will not count toward a "Yes" resolution.
The primary resolution source for this market is official information from the U.S. Senate; however, a consensus of credible reporting may also be used.
音量
$19,662終了日
2027/01/01マーケット開始日
Aug 20, 2026, 5:43 PM ETリゾルバー
0x65070BE91...Trump nominated White House domestic policy aide Dr. Heidi Overton on August 18-19, 2026, to serve as FDA Commissioner following the May resignation of Dr. Marty Makary. Overton, a physician and deputy director of the Domestic Policy Council with prior ties to the America First Policy Institute, must secure Senate confirmation through the narrowly Republican-controlled HELP Committee chaired by Sen. Bill Cassidy. Cassidy has voiced strong reservations over her limited managerial experience and role in recent vaccine-related executive actions. The agency continues operating under Acting Commissioner Kyle Diamantas amid ongoing staff turnover and leadership stabilization moves announced in early September. Confirmation timing and outcome hinge on committee hearings, potential holds, and floor vote dynamics in a divided Senate.
Polymarketデータを参照したAI生成の実験的な要約。これは取引アドバイスではなく、このマーケットの解決方法には一切関係ありません。 · 更新日
外部リンクに注意してください。
外部リンクに注意してください。
よくある質問